PDE5 inhibitor protects testes

被引:1
|
作者
Sarah Payton
机构
关键词
D O I
10.1038/nrurol.2012.170
中图分类号
学科分类号
摘要
引用
收藏
页码:477 / 477
相关论文
共 50 条
  • [1] PDE5 inhibitor protects the mitochondrial function of hypoxic myocardial cells
    Jia, Haiyan
    Guo, Zhen
    Yao, Yanfen
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (01) : 199 - 204
  • [2] PDE5 INHIBITOR PRESCRIBING IN HYPERTENSION
    Mita, K.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S189 - S189
  • [3] PDE5 inhibitor drugs for use in dementia
    Hainsworth, Atticus H.
    Arancio, Ottavio
    Elahi, Fanny M.
    Isaacs, Jeremy D.
    Cheng, Feixiong
    [J]. ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2023, 9 (03)
  • [4] Vardenafil - PDE5 inhibitor number 3
    Jackson, G
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (03) : 229 - 229
  • [5] Alternative Synthesis of Tadalafil: PDE5 Inhibitor
    Anumula, Raghupathi Reddy
    Madivada, Lokeswara Rao
    Gilla, Goverdhan
    Raju, V. V. N. K. Prasad
    Kagga, Mukkanti
    Reddy, Padi Pratap
    Bhattacharya, Apurba
    Bandichhor, Rakeshwar
    [J]. SYNTHETIC COMMUNICATIONS, 2008, 38 (23) : 4265 - 4271
  • [6] NEGOTIATING PDE5 INHIBITOR USE IN COUPLES
    Hundertmark, James
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2009, 43 : A29 - A29
  • [7] Cardiovascular profile of tadalafil, a new PDE5 inhibitor
    Kloner, RA
    Watkins, VS
    Costigan, TM
    Bedding, A
    Mitchell, MI
    Emmick, J
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 176 - 176
  • [8] Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED
    Boyle, CD
    Xu, R
    Asberom, T
    Chackalamannil, S
    Clader, JW
    Greenlee, WJ
    Guzik, H
    Hu, YQ
    Hu, ZY
    Lankin, CM
    Pissarnitski, DA
    Stamford, AW
    Wang, YG
    Skell, J
    Kurowski, S
    Vemulapalli, S
    Palamanda, J
    Chintala, M
    Wu, P
    Myers, J
    Wang, P
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2365 - 2369
  • [9] Cardiovascular implications in the use of PDE5 inhibitor therapy
    Maurice, DH
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (Suppl 1) : S20 - S23
  • [10] Cardiovascular profile of tadalafil, a new PDE5 inhibitor
    Mitchell, M
    Watkins, V
    Costigan, T
    Bedding, A
    Emmick, J
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 : S249 - S249